Brief: Sequana Medical: First Patient Enrolled In North American Alfapump Pivotal Study (Poseidon)

Sequana Medical NV

25/09/2019 06:13

Sept 25 (Reuters) - SEQUANA MEDICAL NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN NORTH AMERICAN ALFAPUMP® PIVOTAL STUDY
(POSEIDON)
    * RESULTS ANTICIPATED BY MID-2021
    * STUDY AIMS TO SUPPORT APPROVAL OF ALFAPUMP IN U.S. AND CANADA
    * U.S. LAUNCH OF ALFAPUMP PLANNED FOR H1 2022

Source text for Eikon:  ID:nGNX7sMbyg 
See also:  urn:newsml:reuters.com:*:nFWN26F0LP
Further company coverage:  SEQUA.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))